![](/img/cover-not-exists.png)
P261 Clinical effect of lumacaftor/ivacaftor in F508del homozygous cystic fibrosis patients with FEV1 ≥90% predicted at baseline
Aalbers, B.L., de Winter-de Groot, K.M., Arets, H.G.M., Hofland, R.W., de Kiviet, A.C., van Oirschot-van de Ven, M.M.M., Kruijswijk, M.A., Schotman, S., Michel, S., van der Ent, C.K., Heijerman, H.G.MVolume:
18
Language:
english
Journal:
Journal of Cystic Fibrosis
DOI:
10.1016/S1569-1993(19)30554-5
Date:
June, 2019
File:
PDF, 82 KB
english, 2019